Ravi Parthasarathy, a seasoned product development team leader with extensive experience in the medical device industry, has been appointed as the new Chief Technology Officer at Diality Inc., a California-based medical device company. Prior to joining Diality, Parthasarathy worked as Vice President of Device Engineering at ICU Medical and held leadership positions at Baxter Healthcare, Motorola, Siemens Medical Systems, and General Motors.
Diality’s CEO, Osman Khawar, M.D., expressed his excitement about Parthasarathy joining the team. He stated that the new CTO’s expertise and alignment with Diality’s mission, vision, and values make him an ideal fit for the company. As Diality continues to grow and expand its operations, Clayton Poppe will transition into the role of Chief Scientific Officer (CSO), overseeing research, quality control and regulatory functions.
Parthasarathy is highly excited about joining Diality and shared his enthusiasm for the company’s mission of improving the lives of those affected by kidney disease through innovative solutions that prioritize patient care. The Moda-flxTM Hemodialysis System developed by Diality is a prime example of this commitment to excellence in patient care. The system is designed to empower healthcare professionals to make informed decisions that benefit patients while also supporting their clinical practice needs.
Diality is dedicated to delivering high-quality products that improve the overall well-being of dialysis patients. The Moda-flxTM Hemodialysis System is currently under development but promises to be a game changer in the industry. For more information about Diality and its products visit www.diality.com or find them on LinkedIn. For media inquiries please contact Sam Choinski at schoinski@pazangahealth.com or (860) 301-5058